UT College of Pharmacy and Pharmaceutical Sciences News

UT Health’s Dr. Sari comments on buprenorphine

Just months ago, the Ohio legislature approved the use of buprenorphine, an ingredient in the drug Suboxone, for the treatment of opioid dependence. Dr. Youssef Sari commented on the use and safety of this medication in an interview on WTOL 11.

Dr. Sari is an associate professor in the Department of Pharmacology and Experimental Therapeutics. Visit his faculty page for more information about his research.

Tags: , , , , , , , , ,

is the Scientific Editor and College Communicator for The University of Toledo College of Pharmacy and Pharmaceutical Sciences. She is a triple alumna of The University of Toledo with master's degrees in English and Education and a graduate certificate in Patient Advocacy.
Email this author | All posts by


Leave a Reply